newsfilter
← Latest News
Business Wire·

Infinity to Present at the Piper Sandler 33rd Annual Virtual Healthcare Conference

Infinity Pharmaceuticals, Inc. (NASDAQ:INFI), a clinical-stage biotechnology company developing eganelisib, a potentially first-in-class, oral, immuno-oncology macrophage reprogramming therapeutic which addresses a fundamental biologic mechanism of immu